Ozempic (Semaglutide) is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as: I. an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. II. to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. III. an adjunct to diet and exercise to improve glycemic control in adults w...